466 related articles for article (PubMed ID: 34731685)
1. Predictors of respiratory bacterial co-infection in hospitalized COVID-19 patients.
Bolker A; Coe K; Smith J; Stevenson K; Wang SH; Reed E
Diagn Microbiol Infect Dis; 2022 Jan; 102(1):115558. PubMed ID: 34731685
[TBL] [Abstract][Full Text] [Related]
2. Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting.
Hughes S; Troise O; Donaldson H; Mughal N; Moore LSP
Clin Microbiol Infect; 2020 Oct; 26(10):1395-1399. PubMed ID: 32603803
[TBL] [Abstract][Full Text] [Related]
3. Antibiotic Use and Bacterial Infection among Inpatients in the First Wave of COVID-19: a Retrospective Cohort Study of 64,691 Patients.
Baghdadi JD; Coffey KC; Adediran T; Goodman KE; Pineles L; Magder LS; O'Hara LM; Pineles BL; Nadimpalli G; Morgan DJ; Harris AD
Antimicrob Agents Chemother; 2021 Oct; 65(11):e0134121. PubMed ID: 34491806
[TBL] [Abstract][Full Text] [Related]
4. Clinical characteristics and co-infections of 354 hospitalized patients with COVID-19 in Wuhan, China: a retrospective cohort study.
Lv Z; Cheng S; Le J; Huang J; Feng L; Zhang B; Li Y
Microbes Infect; 2020; 22(4-5):195-199. PubMed ID: 32425649
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for bacterial infections in patients with moderate to severe COVID-19: A case-control study.
Nasir N; Rehman F; Omair SF
J Med Virol; 2021 Jul; 93(7):4564-4569. PubMed ID: 33822390
[TBL] [Abstract][Full Text] [Related]
6. Low frequency of community-acquired bacterial co-infection in patients hospitalized for COVID-19 based on clinical, radiological and microbiological criteria: a retrospective cohort study.
Coenen S; de la Court JR; Buis DTP; Meijboom LJ; Schade RP; Visser CE; van Hest R; Kuijvenhoven M; Prins JM; Nijman SFM; Sieswerda E; Sigaloff KCE
Antimicrob Resist Infect Control; 2021 Oct; 10(1):155. PubMed ID: 34717761
[TBL] [Abstract][Full Text] [Related]
7. State-of-the-art review of secondary pulmonary infections in patients with COVID-19 pneumonia.
Chong WH; Saha BK; Ananthakrishnan Ramani ; Chopra A
Infection; 2021 Aug; 49(4):591-605. PubMed ID: 33709380
[TBL] [Abstract][Full Text] [Related]
8. Few bacterial co-infections but frequent empiric antibiotic use in the early phase of hospitalized patients with COVID-19: results from a multicentre retrospective cohort study in The Netherlands.
Karami Z; Knoop BT; Dofferhoff ASM; Blaauw MJT; Janssen NA; van Apeldoorn M; Kerckhoffs APM; van de Maat JS; Hoogerwerf JJ; Ten Oever J
Infect Dis (Lond); 2021 Feb; 53(2):102-110. PubMed ID: 33103530
[TBL] [Abstract][Full Text] [Related]
9. The clinical impact of bacterial co-infection among moderate, severe and critically ill COVID-19 patients in the second referral hospital in Surabaya.
Asmarawati TP; Rosyid AN; Suryantoro SD; Mahdi BA; Windradi C; Wulaningrum PA; Arifianto MV; Bramantono B; Triyono EA; Rusli M; Rachman BE; Marfiani E; Endraswari PD; Hadi U; Kuntaman K; Nasronudin N
F1000Res; 2021; 10():113. PubMed ID: 33868645
[No Abstract] [Full Text] [Related]
10. Incidence and risk factors for clinically confirmed secondary bacterial infections in patients hospitalized for coronavirus disease 2019 (COVID-19).
Park HS; McCracken CM; Lininger N; Varley CD; Sikka MK; Evans C; Villamagna AH; Makadia JT; McGregor JC
Infect Control Hosp Epidemiol; 2023 Oct; 44(10):1650-1656. PubMed ID: 37184033
[TBL] [Abstract][Full Text] [Related]
11. National surveillance of bacterial and fungal coinfection and secondary infection in COVID-19 patients in England: lessons from the first wave.
Gerver SM; Guy R; Wilson K; Thelwall S; Nsonwu O; Rooney G; Brown CS; Muller-Pebody B; Hope R; Hall V
Clin Microbiol Infect; 2021 Nov; 27(11):1658-1665. PubMed ID: 34481722
[TBL] [Abstract][Full Text] [Related]
12. Elevated procalcitonin concentrations in severe Covid-19 may not reflect bacterial co-infection.
Heer RS; Mandal AK; Kho J; Szawarski P; Csabi P; Grenshaw D; Walker IA; Missouris CG
Ann Clin Biochem; 2021 Sep; 58(5):520-527. PubMed ID: 34018843
[TBL] [Abstract][Full Text] [Related]
13. Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis.
Langford BJ; So M; Raybardhan S; Leung V; Westwood D; MacFadden DR; Soucy JR; Daneman N
Clin Microbiol Infect; 2020 Dec; 26(12):1622-1629. PubMed ID: 32711058
[TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 and HIV coinfection: clinical experience from Rhode Island, United States.
Byrd KM; Beckwith CG; Garland JM; Johnson JE; Aung S; Cu-Uvin S; Farmakiotis D; Flanigan T; Gillani FS; Macias-Gil R; Mileno M; Ramratnam B; Rybak NR; Sanchez M; Tashima K; Mylonakis E; Kantor R
J Int AIDS Soc; 2020 Jul; 23(7):e25573. PubMed ID: 32657527
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of Co-Infections with Respiratory Viruses in Individuals Investigated for SARS-CoV-2 in Ontario, Canada.
Peci A; Tran V; Guthrie JL; Li Y; Nelson P; Schwartz KL; Eshaghi A; Buchan SA; Gubbay JB
Viruses; 2021 Jan; 13(1):. PubMed ID: 33477649
[TBL] [Abstract][Full Text] [Related]
16. Coinfections among hospitalized patients with covid-19 in the first pandemic wave.
Zamora-Cintas MI; López DJ; Blanco AC; Rodriguez TM; Segarra JM; Novales JM; Ferriol MFR; Maestre MM; Sacristán MS
Diagn Microbiol Infect Dis; 2021 Nov; 101(3):115416. PubMed ID: 34391076
[TBL] [Abstract][Full Text] [Related]
17. Impact of respiratory bacterial infections on mortality in Japanese patients with COVID-19: a retrospective cohort study.
Nakagawara K; Kamata H; Chubachi S; Namkoong H; Tanaka H; Lee H; Otake S; Fukushima T; Kusumoto T; Morita A; Azekawa S; Watase M; Asakura T; Masaki K; Ishii M; Endo A; Koike R; Ishikura H; Takata T; Matsushita Y; Harada N; Kokutou H; Yoshiyama T; Kataoka K; Mutoh Y; Miyawaki M; Ueda S; Ono H; Ono T; Shoko T; Muranaka H; Kawamura K; Mori N; Mochimaru T; Fukui M; Chihara Y; Nagasaki Y; Okamoto M; Amishima M; Odani T; Tani M; Nishi K; Shirai Y; Edahiro R; Ando A; Hashimoto N; Ogura S; Kitagawa Y; Kita T; Kagaya T; Kimura Y; Miyazawa N; Tsuchida T; Fujitani S; Murakami K; Sano H; Sato Y; Tanino Y; Otsuki R; Mashimo S; Kuramochi M; Hosoda Y; Hasegawa Y; Ueda T; Takaku Y; Ishiguro T; Fujiwara A; Kuwahara N; Kitamura H; Hagiwara E; Nakamori Y; Saito F; Kono Y; Abe S; Ishii T; Ohba T; Kusaka Y; Watanabe H; Masuda M; Watanabe H; Kimizuka Y; Kawana A; Kasamatsu Y; Hashimoto S; Okada Y; Takano T; Katayama K; Ai M; Kumanogoh A; Sato T; Tokunaga K; Imoto S; Kitagawa Y; Kimura A; Miyano S; Hasegawa N; Ogawa S; Kanai T; Fukunaga K;
BMC Pulm Med; 2023 Apr; 23(1):146. PubMed ID: 37101265
[TBL] [Abstract][Full Text] [Related]
18. Empiric Antibacterial Therapy and Community-onset Bacterial Coinfection in Patients Hospitalized With Coronavirus Disease 2019 (COVID-19): A Multi-hospital Cohort Study.
Vaughn VM; Gandhi TN; Petty LA; Patel PK; Prescott HC; Malani AN; Ratz D; McLaughlin E; Chopra V; Flanders SA
Clin Infect Dis; 2021 May; 72(10):e533-e541. PubMed ID: 32820807
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic yield of bacteriological tests and predictors of severe outcome in adult patients with COVID-19 presenting to the emergency department.
Kaal A; Snel L; Dane M; van Burgel N; Ottens T; Broekman W; El Bouazzaoui L; Kolfschoten N; Schippers E; Steyerberg E; Meziyerh S; van Nieuwkoop C
Emerg Med J; 2021 Sep; 38(9):685-691. PubMed ID: 34289966
[TBL] [Abstract][Full Text] [Related]
20. Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis.
Langford BJ; So M; Raybardhan S; Leung V; Soucy JR; Westwood D; Daneman N; MacFadden DR
Clin Microbiol Infect; 2021 Apr; 27(4):520-531. PubMed ID: 33418017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
